.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Postoperative immobilization after rotator cuff repair is intended to protect the repair, but prolonged restriction can increase stiffness. This randomized trial compared early active mobilisation with a conventional rehabilitation strategy after mini-open rotator cuff repair. At six weeks, the early-mobilisation group had better abduction and elevation. By three months and beyond, the early advantage disappeared, and at two years the groups had similar clinical outcomes. The study provides reassurance that carefully controlled early movement does not necessarily compromise longer-term recovery. For HCPs, the practical message is to individualise rehabilitation according to tear size, tissue quality and repair security rather than applying prolonged immobilization universally. Early movement should remain pain-free and controlled, with progression guided by the surgeon and physiotherapist. The trial also highlights the difference between an early range-of-motion benefit and a durable patient-reported advantage: faster early motion did not translate into dramatically different two-year outcomes. Rehabilitation should therefore aim to balance tendon protection with prevention of stiffness and restoration of function.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Postoperative immobilization after rotator cuff repair is intended to protect the repair, but prolonged restriction can increase stiffness. This randomized trial compared early active mobilisation with a conventional rehabilitation strategy after mini-open rotator cuff repair. At six weeks, the early-mobilisation group had better abduction and elevation. By three months and beyond, the early advantage disappeared, and at two years the groups had similar clinical outcomes. The study provides reassurance that carefully controlled early movement does not necessarily compromise longer-term recovery. For HCPs, the practical message is to individualise rehabilitation according to tear size, tissue quality and repair security rather than applying prolonged immobilization universally. Early movement should remain pain-free and controlled, with progression guided by the surgeon and physiotherapist. The trial also highlights the difference between an early range-of-motion benefit and a durable patient-reported advantage: faster early motion did not translate into dramatically different two-year outcomes. Rehabilitation should therefore aim to balance tendon protection with prevention of stiffness and restoration of function.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
